ExpreS2ion announces financial results for the third quarter of 2021
Hørsholm, Denmark, November 15, 2021 – ExpreS2ion Biotech Holding AB (“ExpreS2ion”) today announces its third quarter financial results for 2021. The report is available as an attachment and on ExpreS2ion's website (www.expres2ionbio.com). Below is a summary of the report.CEO Bent U. Frandsen comments “Our news flow for the third quarter was dominated by strong achievements in the ABNCoV2 COVID-19 vaccine program, but we are also progressing in our pipeline projects, including our leading HER2-cVLP breast cancer vaccine project. We also saw continued momentum in our malaria projects with